BDM

BRODIMOPRIM-4,6-DICARBOXYLATE

Find entries where: BDM

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	BRODIMOPRIM-4,6-DICARBOXYLATE
Identifiers	(2S)-2-[3-[2-bromo-5-[(2,4-diaminopyrimidin-1-ium-5-yl)methyl]-3-methoxy-phenoxy]propyl]pentanedioate
Formula	C₂₀ H₂₄ Br N₄ O₆
Molecular Weight	496.332
Type	NON-POLYMER
Isomeric SMILES	COc1cc(cc(c1Br)OCCC[C@@H](CCC(=O)[O-])C(=O)[O-])Cc2c[nH+]c(nc2N)N
InChI	InChI=1S/C20H25BrN4O6/c1-30-14-8-11(7-13-10-24-20(23)25-18(13)22)9-15(17(14)21)31-6-2-3-12(19(28)29)4-5-16(26)27/h8-10,12H,2-7H2,1H3,(H,26,27)(H,28,29)(H4,22,23,24,25)/p-1/t12-/m0/s1
InChIKey	SZAVCZNFKJSWRN-LBPRGKRZSA-M

Chemical Details
Formal Charge	-1
Atom Count	55
Chiral Atom Count	1
Bond Count	56
Aromatic Bond Count	12

Drug Info: DrugBank

DrugBank ID	DB02809
Name	Brodimoprim-4,6-Dicarboxylate
Groups	experimental
Description	Brodimoprim-4,6-dicarboxylate is a solid. This compound belongs to the anisoles. These are organic compounds contaiing a methoxybenzene or a derivative thereof. This medication is known to target the protein dihydrofolate reductase.
Synonyms	Brodimoprim-4,6-Dicarboxylate

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Dihydrofolate reductase	MTAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESF...	unknown

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682